Bisphosphonates are a drugs that treat bone problems, such as thin or fragile bones. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.

The global Bisphosphonates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Bisphosphonates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bisphosphonates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Bisphosphonates include Merck, Teva, Mylan, Apotex Corp, Pfizer, Sanofi, Roche, Novartis and Eli Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bisphosphonates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bisphosphonates.

Report Scope

The Bisphosphonates market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bisphosphonates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bisphosphonates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bisphosphonates Market Report

Report Metric	Details
Report Name	Bisphosphonates Market
Segment by Type	Alendronate Ibandronate Risedronate Zoledronic Acid
Segment by Application	Metastatic Bone Cancers Systemic Metabolic Bone Diseases
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Teva, Mylan, Apotex Corp, Pfizer, Sanofi, Roche, Novartis, Eli Lilly, Amgen, Tecoland, Emcure Pharma, Taj Pharmaceuticals, Natco Pharma, Scinopharm Taiwan, Lianyungang Runzhong Pharmaceutical, Hangzhou Longshine Bio-Tech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bisphosphonates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bisphosphonates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bisphosphonates Market report?

Ans: The main players in the Bisphosphonates Market are Merck, Teva, Mylan, Apotex Corp, Pfizer, Sanofi, Roche, Novartis, Eli Lilly, Amgen, Tecoland, Emcure Pharma, Taj Pharmaceuticals, Natco Pharma, Scinopharm Taiwan, Lianyungang Runzhong Pharmaceutical, Hangzhou Longshine Bio-Tech

What are the Application segmentation covered in the Bisphosphonates Market report?

Ans: The Applications covered in the Bisphosphonates Market report are Metastatic Bone Cancers, Systemic Metabolic Bone Diseases

What are the Type segmentation covered in the Bisphosphonates Market report?

Ans: The Types covered in the Bisphosphonates Market report are Alendronate, Ibandronate, Risedronate, Zoledronic Acid

1 Bisphosphonates Market Overview

1.1 Product Overview and Scope of Bisphosphonates

1.2 Bisphosphonates Segment by Type

1.2.1 Global Bisphosphonates Market Value Comparison by Type (2024-2030)

1.2.2 Alendronate

1.2.3 Ibandronate

1.2.4 Risedronate

1.2.5 Zoledronic Acid

1.3 Bisphosphonates Segment by Application

1.3.1 Global Bisphosphonates Market Value by Application: (2024-2030)

1.3.2 Metastatic Bone Cancers

1.3.3 Systemic Metabolic Bone Diseases

1.4 Global Bisphosphonates Market Size Estimates and Forecasts

1.4.1 Global Bisphosphonates Revenue 2019-2030

1.4.2 Global Bisphosphonates Sales 2019-2030

1.4.3 Global Bisphosphonates Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Bisphosphonates Market Competition by Manufacturers

2.1 Global Bisphosphonates Sales Market Share by Manufacturers (2019-2024)

2.2 Global Bisphosphonates Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Bisphosphonates Average Price by Manufacturers (2019-2024)

2.4 Global Bisphosphonates Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bisphosphonates, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bisphosphonates, Product Type & Application

2.7 Bisphosphonates Market Competitive Situation and Trends

2.7.1 Bisphosphonates Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Bisphosphonates Players Market Share by Revenue

2.7.3 Global Bisphosphonates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bisphosphonates Retrospective Market Scenario by Region

3.1 Global Bisphosphonates Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Bisphosphonates Global Bisphosphonates Sales by Region: 2019-2030

3.2.1 Global Bisphosphonates Sales by Region: 2019-2024

3.2.2 Global Bisphosphonates Sales by Region: 2025-2030

3.3 Global Bisphosphonates Global Bisphosphonates Revenue by Region: 2019-2030

3.3.1 Global Bisphosphonates Revenue by Region: 2019-2024

3.3.2 Global Bisphosphonates Revenue by Region: 2025-2030

3.4 North America Bisphosphonates Market Facts & Figures by Country

3.4.1 North America Bisphosphonates Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Bisphosphonates Sales by Country (2019-2030)

3.4.3 North America Bisphosphonates Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Bisphosphonates Market Facts & Figures by Country

3.5.1 Europe Bisphosphonates Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Bisphosphonates Sales by Country (2019-2030)

3.5.3 Europe Bisphosphonates Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bisphosphonates Market Facts & Figures by Country

3.6.1 Asia Pacific Bisphosphonates Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Bisphosphonates Sales by Country (2019-2030)

3.6.3 Asia Pacific Bisphosphonates Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Bisphosphonates Market Facts & Figures by Country

3.7.1 Latin America Bisphosphonates Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Bisphosphonates Sales by Country (2019-2030)

3.7.3 Latin America Bisphosphonates Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bisphosphonates Market Facts & Figures by Country

3.8.1 Middle East and Africa Bisphosphonates Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Bisphosphonates Sales by Country (2019-2030)

3.8.3 Middle East and Africa Bisphosphonates Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Bisphosphonates Sales by Type (2019-2030)

4.1.1 Global Bisphosphonates Sales by Type (2019-2024)

4.1.2 Global Bisphosphonates Sales by Type (2025-2030)

4.1.3 Global Bisphosphonates Sales Market Share by Type (2019-2030)

4.2 Global Bisphosphonates Revenue by Type (2019-2030)

4.2.1 Global Bisphosphonates Revenue by Type (2019-2024)

4.2.2 Global Bisphosphonates Revenue by Type (2025-2030)

4.2.3 Global Bisphosphonates Revenue Market Share by Type (2019-2030)

4.3 Global Bisphosphonates Price by Type (2019-2030)

5 Segment by Application

5.1 Global Bisphosphonates Sales by Application (2019-2030)

5.1.1 Global Bisphosphonates Sales by Application (2019-2024)

5.1.2 Global Bisphosphonates Sales by Application (2025-2030)

5.1.3 Global Bisphosphonates Sales Market Share by Application (2019-2030)

5.2 Global Bisphosphonates Revenue by Application (2019-2030)

5.2.1 Global Bisphosphonates Revenue by Application (2019-2024)

5.2.2 Global Bisphosphonates Revenue by Application (2025-2030)

5.2.3 Global Bisphosphonates Revenue Market Share by Application (2019-2030)

5.3 Global Bisphosphonates Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Bisphosphonates Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Teva

6.2.1 Teva Corporation Information

6.2.2 Teva Description and Business Overview

6.2.3 Teva Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Teva Bisphosphonates Product Portfolio

6.2.5 Teva Recent Developments/Updates

6.3 Mylan

6.3.1 Mylan Corporation Information

6.3.2 Mylan Description and Business Overview

6.3.3 Mylan Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Mylan Bisphosphonates Product Portfolio

6.3.5 Mylan Recent Developments/Updates

6.4 Apotex Corp

6.4.1 Apotex Corp Corporation Information

6.4.2 Apotex Corp Description and Business Overview

6.4.3 Apotex Corp Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Apotex Corp Bisphosphonates Product Portfolio

6.4.5 Apotex Corp Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Corporation Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Pfizer Bisphosphonates Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Sanofi

6.6.1 Sanofi Corporation Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sanofi Bisphosphonates Product Portfolio

6.6.5 Sanofi Recent Developments/Updates

6.7 Roche

6.6.1 Roche Corporation Information

6.6.2 Roche Description and Business Overview

6.6.3 Roche Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Roche Bisphosphonates Product Portfolio

6.7.5 Roche Recent Developments/Updates

6.8 Novartis

6.8.1 Novartis Corporation Information

6.8.2 Novartis Description and Business Overview

6.8.3 Novartis Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Novartis Bisphosphonates Product Portfolio

6.8.5 Novartis Recent Developments/Updates

6.9 Eli Lilly

6.9.1 Eli Lilly Corporation Information

6.9.2 Eli Lilly Description and Business Overview

6.9.3 Eli Lilly Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Eli Lilly Bisphosphonates Product Portfolio

6.9.5 Eli Lilly Recent Developments/Updates

6.10 Amgen

6.10.1 Amgen Corporation Information

6.10.2 Amgen Description and Business Overview

6.10.3 Amgen Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Amgen Bisphosphonates Product Portfolio

6.10.5 Amgen Recent Developments/Updates

6.11 Tecoland

6.11.1 Tecoland Corporation Information

6.11.2 Tecoland Bisphosphonates Description and Business Overview

6.11.3 Tecoland Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Tecoland Bisphosphonates Product Portfolio

6.11.5 Tecoland Recent Developments/Updates

6.12 Emcure Pharma

6.12.1 Emcure Pharma Corporation Information

6.12.2 Emcure Pharma Bisphosphonates Description and Business Overview

6.12.3 Emcure Pharma Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Emcure Pharma Bisphosphonates Product Portfolio

6.12.5 Emcure Pharma Recent Developments/Updates

6.13 Taj Pharmaceuticals

6.13.1 Taj Pharmaceuticals Corporation Information

6.13.2 Taj Pharmaceuticals Bisphosphonates Description and Business Overview

6.13.3 Taj Pharmaceuticals Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Taj Pharmaceuticals Bisphosphonates Product Portfolio

6.13.5 Taj Pharmaceuticals Recent Developments/Updates

6.14 Natco Pharma

6.14.1 Natco Pharma Corporation Information

6.14.2 Natco Pharma Bisphosphonates Description and Business Overview

6.14.3 Natco Pharma Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Natco Pharma Bisphosphonates Product Portfolio

6.14.5 Natco Pharma Recent Developments/Updates

6.15 Scinopharm Taiwan

6.15.1 Scinopharm Taiwan Corporation Information

6.15.2 Scinopharm Taiwan Bisphosphonates Description and Business Overview

6.15.3 Scinopharm Taiwan Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Scinopharm Taiwan Bisphosphonates Product Portfolio

6.15.5 Scinopharm Taiwan Recent Developments/Updates

6.16 Lianyungang Runzhong Pharmaceutical

6.16.1 Lianyungang Runzhong Pharmaceutical Corporation Information

6.16.2 Lianyungang Runzhong Pharmaceutical Bisphosphonates Description and Business Overview

6.16.3 Lianyungang Runzhong Pharmaceutical Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Lianyungang Runzhong Pharmaceutical Bisphosphonates Product Portfolio

6.16.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates

6.17 Hangzhou Longshine Bio-Tech

6.17.1 Hangzhou Longshine Bio-Tech Corporation Information

6.17.2 Hangzhou Longshine Bio-Tech Bisphosphonates Description and Business Overview

6.17.3 Hangzhou Longshine Bio-Tech Bisphosphonates Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Hangzhou Longshine Bio-Tech Bisphosphonates Product Portfolio

6.17.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bisphosphonates Industry Chain Analysis

7.2 Bisphosphonates Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bisphosphonates Production Mode & Process

7.4 Bisphosphonates Sales and Marketing

7.4.1 Bisphosphonates Sales Channels

7.4.2 Bisphosphonates Distributors

7.5 Bisphosphonates Customers

8 Bisphosphonates Market Dynamics

8.1 Bisphosphonates Industry Trends

8.2 Bisphosphonates Market Drivers

8.3 Bisphosphonates Market Challenges

8.4 Bisphosphonates Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Lianyungang Runzhong Pharmaceutical

Hangzhou Longshine Bio-Tech

List of Tables

Table 1. Global Bisphosphonates Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Bisphosphonates Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Bisphosphonates Market Competitive Situation by Manufacturers in 2023

Table 4. Global Bisphosphonates Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Bisphosphonates Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Bisphosphonates Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Bisphosphonates Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Bisphosphonates Average Price (USD/Kg) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Bisphosphonates, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bisphosphonates, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bisphosphonates, Product Type & Application

Table 12. Global Key Manufacturers of Bisphosphonates, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bisphosphonates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bisphosphonates as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bisphosphonates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Bisphosphonates Sales by Region (2019-2024) & (MT)

Table 18. Global Bisphosphonates Sales Market Share by Region (2019-2024)

Table 19. Global Bisphosphonates Sales by Region (2025-2030) & (MT)

Table 20. Global Bisphosphonates Sales Market Share by Region (2025-2030)

Table 21. Global Bisphosphonates Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Bisphosphonates Revenue Market Share by Region (2019-2024)

Table 23. Global Bisphosphonates Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Bisphosphonates Revenue Market Share by Region (2025-2030)

Table 25. North America Bisphosphonates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Bisphosphonates Sales by Country (2019-2024) & (MT)

Table 27. North America Bisphosphonates Sales by Country (2025-2030) & (MT)

Table 28. North America Bisphosphonates Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Bisphosphonates Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Bisphosphonates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Bisphosphonates Sales by Country (2019-2024) & (MT)

Table 32. Europe Bisphosphonates Sales by Country (2025-2030) & (MT)

Table 33. Europe Bisphosphonates Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Bisphosphonates Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Bisphosphonates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Bisphosphonates Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Bisphosphonates Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Bisphosphonates Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Bisphosphonates Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Bisphosphonates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Bisphosphonates Sales by Country (2019-2024) & (MT)

Table 42. Latin America Bisphosphonates Sales by Country (2025-2030) & (MT)

Table 43. Latin America Bisphosphonates Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Bisphosphonates Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Bisphosphonates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Bisphosphonates Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Bisphosphonates Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Bisphosphonates Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Bisphosphonates Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Bisphosphonates Sales (MT) by Type (2019-2024)

Table 51. Global Bisphosphonates Sales (MT) by Type (2025-2030)

Table 52. Global Bisphosphonates Sales Market Share by Type (2019-2024)

Table 53. Global Bisphosphonates Sales Market Share by Type (2025-2030)

Table 54. Global Bisphosphonates Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Bisphosphonates Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Bisphosphonates Revenue Market Share by Type (2019-2024)

Table 57. Global Bisphosphonates Revenue Market Share by Type (2025-2030)

Table 58. Global Bisphosphonates Price (USD/Kg) by Type (2019-2024)

Table 59. Global Bisphosphonates Price (USD/Kg) by Type (2025-2030)

Table 60. Global Bisphosphonates Sales (MT) by Application (2019-2024)

Table 61. Global Bisphosphonates Sales (MT) by Application (2025-2030)

Table 62. Global Bisphosphonates Sales Market Share by Application (2019-2024)

Table 63. Global Bisphosphonates Sales Market Share by Application (2025-2030)

Table 64. Global Bisphosphonates Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Bisphosphonates Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Bisphosphonates Revenue Market Share by Application (2019-2024)

Table 67. Global Bisphosphonates Revenue Market Share by Application (2025-2030)

Table 68. Global Bisphosphonates Price (USD/Kg) by Application (2019-2024)

Table 69. Global Bisphosphonates Price (USD/Kg) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 73. Merck Bisphosphonates Product

Table 74. Merck Recent Developments/Updates

Table 75. Teva Corporation Information

Table 76. Teva Description and Business Overview

Table 77. Teva Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 78. Teva Bisphosphonates Product

Table 79. Teva Recent Developments/Updates

Table 80. Mylan Corporation Information

Table 81. Mylan Description and Business Overview

Table 82. Mylan Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 83. Mylan Bisphosphonates Product

Table 84. Mylan Recent Developments/Updates

Table 85. Apotex Corp Corporation Information

Table 86. Apotex Corp Description and Business Overview

Table 87. Apotex Corp Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 88. Apotex Corp Bisphosphonates Product

Table 89. Apotex Corp Recent Developments/Updates

Table 90. Pfizer Corporation Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 93. Pfizer Bisphosphonates Product

Table 94. Pfizer Recent Developments/Updates

Table 95. Sanofi Corporation Information

Table 96. Sanofi Description and Business Overview

Table 97. Sanofi Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 98. Sanofi Bisphosphonates Product

Table 99. Sanofi Recent Developments/Updates

Table 100. Roche Corporation Information

Table 101. Roche Description and Business Overview

Table 102. Roche Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 103. Roche Bisphosphonates Product

Table 104. Roche Recent Developments/Updates

Table 105. Novartis Corporation Information

Table 106. Novartis Description and Business Overview

Table 107. Novartis Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 108. Novartis Bisphosphonates Product

Table 109. Novartis Recent Developments/Updates

Table 110. Eli Lilly Corporation Information

Table 111. Eli Lilly Description and Business Overview

Table 112. Eli Lilly Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 113. Eli Lilly Bisphosphonates Product

Table 114. Eli Lilly Recent Developments/Updates

Table 115. Amgen Corporation Information

Table 116. Amgen Description and Business Overview

Table 117. Amgen Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 118. Amgen Bisphosphonates Product

Table 119. Amgen Recent Developments/Updates

Table 120. Tecoland Corporation Information

Table 121. Tecoland Description and Business Overview

Table 122. Tecoland Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 123. Tecoland Bisphosphonates Product

Table 124. Tecoland Recent Developments/Updates

Table 125. Emcure Pharma Corporation Information

Table 126. Emcure Pharma Description and Business Overview

Table 127. Emcure Pharma Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 128. Emcure Pharma Bisphosphonates Product

Table 129. Emcure Pharma Recent Developments/Updates

Table 130. Taj Pharmaceuticals Corporation Information

Table 131. Taj Pharmaceuticals Description and Business Overview

Table 132. Taj Pharmaceuticals Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 133. Taj Pharmaceuticals Bisphosphonates Product

Table 134. Taj Pharmaceuticals Recent Developments/Updates

Table 135. Natco Pharma Corporation Information

Table 136. Natco Pharma Description and Business Overview

Table 137. Natco Pharma Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 138. Natco Pharma Bisphosphonates Product

Table 139. Natco Pharma Recent Developments/Updates

Table 140. Scinopharm Taiwan Corporation Information

Table 141. Scinopharm Taiwan Description and Business Overview

Table 142. Scinopharm Taiwan Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 143. Scinopharm Taiwan Bisphosphonates Product

Table 144. Scinopharm Taiwan Recent Developments/Updates

Table 145. Lianyungang Runzhong Pharmaceutical Corporation Information

Table 146. Lianyungang Runzhong Pharmaceutical Description and Business Overview

Table 147. Lianyungang Runzhong Pharmaceutical Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 148. Lianyungang Runzhong Pharmaceutical Bisphosphonates Product

Table 149. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates

Table 150. Hangzhou Longshine Bio-Tech Corporation Information

Table 151. Hangzhou Longshine Bio-Tech Description and Business Overview

Table 152. Hangzhou Longshine Bio-Tech Bisphosphonates Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 153. Hangzhou Longshine Bio-Tech Bisphosphonates Product

Table 154. Hangzhou Longshine Bio-Tech Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Bisphosphonates Distributors List

Table 158. Bisphosphonates Customers List

Table 159. Bisphosphonates Market Trends

Table 160. Bisphosphonates Market Drivers

Table 161. Bisphosphonates Market Challenges

Table 162. Bisphosphonates Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Bisphosphonates

Figure 2. Global Bisphosphonates Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Bisphosphonates Market Share by Type in 2023 & 2030

Figure 4. Alendronate Product Picture

Figure 5. Ibandronate Product Picture

Figure 6. Risedronate Product Picture

Figure 7. Zoledronic Acid Product Picture

Figure 8. Global Bisphosphonates Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Bisphosphonates Market Share by Application in 2023 & 2030

Figure 10. Metastatic Bone Cancers

Figure 11. Systemic Metabolic Bone Diseases

Figure 12. Global Bisphosphonates Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Bisphosphonates Market Size (2019-2030) & (US$ Million)

Figure 14. Global Bisphosphonates Sales (2019-2030) & (MT)

Figure 15. Global Bisphosphonates Average Price (USD/Kg) & (2019-2030)

Figure 16. Bisphosphonates Report Years Considered

Figure 17. Bisphosphonates Sales Share by Manufacturers in 2023

Figure 18. Global Bisphosphonates Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Bisphosphonates Players: Market Share by Revenue in 2023

Figure 20. Bisphosphonates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Bisphosphonates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Bisphosphonates Sales Market Share by Country (2019-2030)

Figure 23. North America Bisphosphonates Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Bisphosphonates Sales Market Share by Country (2019-2030)

Figure 27. Europe Bisphosphonates Revenue Market Share by Country (2019-2030)

Figure 28. Germany Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Bisphosphonates Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Bisphosphonates Revenue Market Share by Region (2019-2030)

Figure 35. China Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Bisphosphonates Sales Market Share by Country (2019-2030)

Figure 46. Latin America Bisphosphonates Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Bisphosphonates Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Bisphosphonates Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Bisphosphonates Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Bisphosphonates by Type (2019-2030)

Figure 56. Global Revenue Market Share of Bisphosphonates by Type (2019-2030)

Figure 57. Global Bisphosphonates Price (USD/Kg) by Type (2019-2030)

Figure 58. Global Sales Market Share of Bisphosphonates by Application (2019-2030)

Figure 59. Global Revenue Market Share of Bisphosphonates by Application (2019-2030)

Figure 60. Global Bisphosphonates Price (USD/Kg) by Application (2019-2030)

Figure 61. Bisphosphonates Value Chain

Figure 62. Bisphosphonates Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions